INTERCONNECTION  ||| S:0 E:16 ||| NNP
BETWEEN  ||| S:16 E:24 ||| NNP
NITRIC  ||| S:24 E:31 ||| NNP
OXIDE  ||| S:31 E:37 ||| NNP
FORMATION  ||| S:37 E:47 ||| NNP
AND  ||| S:47 E:51 ||| CC
HYPERSENSITIVITY  ||| S:51 E:68 ||| NNP
PARAMETERS  ||| S:68 E:79 ||| NNP
UNDER  ||| S:79 E:85 ||| NNP
GUINEA  ||| S:85 E:92 ||| NNP
PIG  ||| S:92 E:96 ||| NNP
MODEL  ||| S:96 E:102 ||| NNP
OF  ||| S:102 E:105 ||| IN
ACUTE  ||| S:105 E:111 ||| NNP
ASTHMA  ||| S:111 E:118 ||| NNP
WITH  ||| S:118 E:123 ||| NNP
MULTIPLE  ||| S:123 E:132 ||| NNP
CHALLENGES  ||| S:132 E:143 ||| NNP
An  ||| S:143 E:146 ||| DT
immunoregulatory  ||| S:146 E:163 ||| JJ
role  ||| S:163 E:168 ||| NN
of  ||| S:168 E:171 ||| IN
nitric  ||| S:171 E:178 ||| JJ
oxide  ||| S:178 E:184 ||| NN
( ||| S:184 E:185 ||| -LRB-
NO ||| S:185 E:187 ||| UH
)  ||| S:187 E:189 ||| -RRB-
in  ||| S:189 E:192 ||| IN
the  ||| S:192 E:196 ||| DT
development  ||| S:196 E:208 ||| NN
of  ||| S:208 E:211 ||| IN
adaptive  ||| S:211 E:220 ||| JJ
immune  ||| S:220 E:227 ||| JJ
responses  ||| S:227 E:237 ||| NNS
associated  ||| S:237 E:248 ||| VBN
with  ||| S:248 E:253 ||| IN
allergic  ||| S:253 E:262 ||| JJ
diseases  ||| S:262 E:271 ||| NNS
is  ||| S:271 E:274 ||| VBZ
very  ||| S:274 E:279 ||| RB
important ||| S:279 E:288 ||| JJ
.  ||| S:288 E:290 ||| .
The  ||| S:290 E:294 ||| DT
present  ||| S:294 E:302 ||| JJ
study  ||| S:302 E:308 ||| NN
extended  ||| S:308 E:317 ||| VBD
these  ||| S:317 E:323 ||| DT
observations  ||| S:323 E:336 ||| NNS
by  ||| S:336 E:339 ||| IN
the  ||| S:339 E:343 ||| DT
examination  ||| S:343 E:355 ||| NN
of  ||| S:355 E:358 ||| IN
the  ||| S:358 E:362 ||| DT
reciprocal  ||| S:362 E:373 ||| JJ
changes  ||| S:373 E:381 ||| NNS
in  ||| S:381 E:384 ||| IN
characteristic  ||| S:384 E:399 ||| JJ
immunologic  ||| S:399 E:411 ||| JJ
parameters  ||| S:411 E:422 ||| NNS
of  ||| S:422 E:425 ||| IN
the  ||| S:425 E:429 ||| DT
disease  ||| S:429 E:437 ||| NN
and  ||| S:437 E:441 ||| CC
NO  ||| S:441 E:444 ||| DT
level  ||| S:444 E:450 ||| NN
of  ||| S:450 E:453 ||| IN
bronchoalveolar  ||| S:453 E:469 ||| JJ
lavage  ||| S:469 E:476 ||| NNS
( ||| S:476 E:477 ||| -LRB-
BAL ||| S:477 E:480 ||| NNP
)  ||| S:480 E:482 ||| -RRB-
cells  ||| S:482 E:488 ||| NNS
under  ||| S:488 E:494 ||| IN
guinea  ||| S:494 E:501 ||| JJ
pig  ||| S:501 E:505 ||| NN
model  ||| S:505 E:511 ||| NN
of  ||| S:511 E:514 ||| IN
acute  ||| S:514 E:520 ||| JJ
asthma  ||| S:520 E:527 ||| NN
with  ||| S:527 E:532 ||| IN
multiple  ||| S:532 E:541 ||| JJ
challenges ||| S:541 E:551 ||| NNS
.  ||| S:551 E:553 ||| .
Development  ||| S:553 E:565 ||| NN
of  ||| S:565 E:568 ||| IN
guinea  ||| S:568 E:575 ||| FW
pig  ||| S:575 E:579 ||| FW
Th2  ||| S:579 E:583 ||| FW
mediated  ||| S:583 E:592 ||| FW
asthma  ||| S:592 E:599 ||| NN
was  ||| S:599 E:603 ||| VBD
accompanied  ||| S:603 E:615 ||| VBN
by  ||| S:615 E:618 ||| IN
increasing  ||| S:618 E:629 ||| VBG
the  ||| S:629 E:633 ||| DT
level  ||| S:633 E:639 ||| NN
of  ||| S:639 E:642 ||| IN
allergic  ||| S:642 E:651 ||| JJ
markers ||| S:651 E:658 ||| NN
:  ||| S:658 E:660 ||| :
ovalbumin  ||| S:660 E:670 ||| CD
( ||| S:670 E:671 ||| -LRB-
OVA ||| S:671 E:674 ||| NNP
)  ||| S:674 E:676 ||| -RRB-
specific  ||| S:676 E:685 ||| JJ
IgG  ||| S:685 E:689 ||| JJ
and  ||| S:689 E:693 ||| CC
IL-4 ||| S:693 E:697 ||| NN
.  ||| S:697 E:699 ||| .
We  ||| S:699 E:702 ||| PRP
demonstrated  ||| S:702 E:715 ||| VBD
that  ||| S:715 E:720 ||| IN
the  ||| S:720 E:724 ||| DT
infiltrate  ||| S:724 E:735 ||| NN
of  ||| S:735 E:738 ||| IN
airway  ||| S:738 E:745 ||| JJ
cells  ||| S:745 E:751 ||| NNS
contributes  ||| S:751 E:763 ||| VBZ
to  ||| S:763 E:766 ||| TO
NO  ||| S:766 E:769 ||| DT
synthesis  ||| S:769 E:779 ||| NN
in  ||| S:779 E:782 ||| IN
the  ||| S:782 E:786 ||| DT
respiratory  ||| S:786 E:798 ||| JJ
tract  ||| S:798 E:804 ||| NN
during  ||| S:804 E:811 ||| IN
allergic  ||| S:811 E:820 ||| JJ
inflammation ||| S:820 E:832 ||| NN
.  ||| S:832 E:834 ||| .
The  ||| S:834 E:838 ||| DT
level  ||| S:838 E:844 ||| NN
of  ||| S:844 E:847 ||| IN
intracellular  ||| S:847 E:861 ||| VBG
NO  ||| S:861 E:864 ||| DT
formation  ||| S:864 E:874 ||| NN
significantly  ||| S:874 E:888 ||| RB
correlated  ||| S:888 E:899 ||| VBN
with  ||| S:899 E:904 ||| IN
plasma  ||| S:904 E:911 ||| JJ
allergen  ||| S:911 E:920 ||| JJ
specific  ||| S:920 E:929 ||| JJ
IgG  ||| S:929 E:933 ||| JJ
value  ||| S:933 E:939 ||| NN
in  ||| S:939 E:942 ||| IN
OVA-induced  ||| S:942 E:954 ||| JJ
asthma ||| S:954 E:960 ||| NN
.  ||| S:960 E:962 ||| .
The  ||| S:962 E:966 ||| DT
presented  ||| S:966 E:976 ||| JJ
data  ||| S:976 E:981 ||| NN
evidence  ||| S:981 E:990 ||| NN
that  ||| S:990 E:995 ||| IN
the  ||| S:995 E:999 ||| DT
elevated  ||| S:999 E:1008 ||| NN
intracellular  ||| S:1008 E:1022 ||| VBD
NO  ||| S:1022 E:1025 ||| DT
level  ||| S:1025 E:1031 ||| NN
in  ||| S:1031 E:1034 ||| IN
BAL  ||| S:1034 E:1038 ||| NNP
fluid  ||| S:1038 E:1044 ||| NN
may  ||| S:1044 E:1048 ||| MD
reflect  ||| S:1048 E:1056 ||| VB
a  ||| S:1056 E:1058 ||| DT
nitrosative  ||| S:1058 E:1070 ||| JJ
stress  ||| S:1070 E:1077 ||| NN
in  ||| S:1077 E:1080 ||| IN
respiratory  ||| S:1080 E:1092 ||| JJ
tract  ||| S:1092 E:1098 ||| NN
in  ||| S:1098 E:1101 ||| IN
general ||| S:1101 E:1108 ||| JJ
,  ||| S:1108 E:1110 ||| ,
when  ||| S:1110 E:1115 ||| WRB
allergic  ||| S:1115 E:1124 ||| JJ
asthma  ||| S:1124 E:1131 ||| NN
exacerbation  ||| S:1131 E:1144 ||| NN
is  ||| S:1144 E:1147 ||| VBZ
present ||| S:1147 E:1154 ||| JJ
.  ||| S:1154 E:1156 ||| .
